These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 10350223)
1. Effect of zafirlukast on cough reflex sensitivity in asthmatics. Dicpinigaitis PV; Dobkin JB J Asthma; 1999 May; 36(3):265-70. PubMed ID: 10350223 [TBL] [Abstract][Full Text] [Related]
2. Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma. Dicpinigaitis PV; Dobkin JB; Reichel J J Asthma; 2002 Jun; 39(4):291-7. PubMed ID: 12095178 [TBL] [Abstract][Full Text] [Related]
3. Leukotriene E(4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma. Laitinen A; Lindqvist A; Halme M; Altraja A; Laitinen LA J Allergy Clin Immunol; 2005 Feb; 115(2):259-65. PubMed ID: 15696079 [TBL] [Abstract][Full Text] [Related]
4. Summary of clinical trials with zafirlukast. Calhoun WJ Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S238-45; discussion S245-8. PubMed ID: 9647606 [TBL] [Abstract][Full Text] [Related]
5. A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy. Smith LJ; Hanby LA; Lavins BJ; Simonson SG Ann Allergy Asthma Immunol; 1998 Jul; 81(1):43-9. PubMed ID: 9690572 [TBL] [Abstract][Full Text] [Related]
6. The leukotriene receptor antagonist zafirlukast inhibits sulfur dioxide-induced bronchoconstriction in patients with asthma. Lazarus SC; Wong HH; Watts MJ; Boushey HA; Lavins BJ; Minkwitz MC Am J Respir Crit Care Med; 1997 Dec; 156(6):1725-30. PubMed ID: 9412547 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma. Kemp JP; Minkwitz MC; Bonuccelli CM; Warren MS Chest; 1999 Feb; 115(2):336-42. PubMed ID: 10027429 [TBL] [Abstract][Full Text] [Related]
8. Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials. Barnes NC; Miller CJ Thorax; 2000 Jun; 55(6):478-83. PubMed ID: 10817796 [TBL] [Abstract][Full Text] [Related]
9. Enhanced prostaglandin E2 secretion in sputum from asthmatic patients after zafirlukast therapy. Tsai JJ; Su YC; Chan SC; Ho CK; Feng TC J Formos Med Assoc; 2001 Apr; 100(4):241-3. PubMed ID: 11393122 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial. Suissa S; Dennis R; Ernst P; Sheehy O; Wood-Dauphinee S Ann Intern Med; 1997 Feb; 126(3):177-83. PubMed ID: 9027267 [TBL] [Abstract][Full Text] [Related]
11. Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma. Kelloway JS Ann Pharmacother; 1997 Sep; 31(9):1012-21. PubMed ID: 9296243 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of montelukast in the treatment of cough variant asthma. Spector SL; Tan RA Ann Allergy Asthma Immunol; 2004 Sep; 93(3):232-6. PubMed ID: 15478381 [TBL] [Abstract][Full Text] [Related]
13. Short-term effect of the addition of leukotriene receptor antagonists to the current therapy in severe asthmatics. Tonelli M; Zingoni M; Bacci E; Dente FL; Di Franco A; Giannini D; Taccola M; Vagaggini B; Paggiaro PL Pulm Pharmacol Ther; 2003; 16(4):237-40. PubMed ID: 12850127 [TBL] [Abstract][Full Text] [Related]
14. Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma. Adkins JC; Brogden RN Drugs; 1998 Jan; 55(1):121-44. PubMed ID: 9463793 [TBL] [Abstract][Full Text] [Related]
15. Zafirlukast improves pulmonary function in patients with moderate persistent asthma receiving regular inhaled steroids: a prospective randomized control study. Huang CJ; Wang CH; Liu WT; Yang MC; Lin HC; Yu CT; Shiao CJ; Tan CC; Yang CK; Kuo HP Chang Gung Med J; 2003 Aug; 26(8):554-60. PubMed ID: 14609035 [TBL] [Abstract][Full Text] [Related]
16. Cough, asthma, and cysteinyl-leukotrienes. Niimi A Pulm Pharmacol Ther; 2013 Oct; 26(5):514-9. PubMed ID: 23774534 [TBL] [Abstract][Full Text] [Related]
17. Separation of cough and reflex bronchoconstriction by inhaled local anaesthetics. Choudry NB; Fuller RW; Anderson N; Karlsson JA Eur Respir J; 1990 May; 3(5):579-83. PubMed ID: 2376253 [TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic modeling of cough responses to capsaicin inhalation calls into question the utility of the C5 end point. Hilton EC; Baverel PG; Woodcock A; Van Der Graaf PH; Smith JA J Allergy Clin Immunol; 2013 Oct; 132(4):847-55.e1-5. PubMed ID: 23777849 [TBL] [Abstract][Full Text] [Related]
19. Cough Reflex Sensitivity in Asthmatic Children. Kunc P; Fabry J; Lucanska M; Zatko T; Grendar M; Pecova R Physiol Res; 2020 Mar; 69(Suppl 1):S147-S150. PubMed ID: 32228020 [TBL] [Abstract][Full Text] [Related]
20. COX-2 inhibition attenuates cough reflex sensitivity to inhaled capsaicin in patients with asthma. Ishiura Y; Fujimura M; Yamamoto H; Ishiguro T; Ohkura N; Myou S J Investig Allergol Clin Immunol; 2009; 19(5):370-4. PubMed ID: 19862936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]